BrightAccountsProduction v1.0.0 v1.0.0 2023-12-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is that of retail pharmacy. 24 April 2025 8 6 NI683454 2024-11-30 NI683454 2023-11-30 NI683454 2022-11-30 NI683454 2023-12-01 2024-11-30 NI683454 2022-12-01 2023-11-30 NI683454 uk-bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 NI683454 uk-curr:PoundSterling 2023-12-01 2024-11-30 NI683454 uk-bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 NI683454 uk-bus:FullAccounts 2023-12-01 2024-11-30 NI683454 uk-bus:Director1 2023-12-01 2024-11-30 NI683454 uk-bus:RegisteredOffice 2023-12-01 2024-11-30 NI683454 uk-bus:Agent1 2023-12-01 2024-11-30 NI683454 uk-core:ShareCapital 2024-11-30 NI683454 uk-core:ShareCapital 2023-11-30 NI683454 uk-core:SharePremium 2024-11-30 NI683454 uk-core:SharePremium 2023-11-30 NI683454 uk-core:RetainedEarningsAccumulatedLosses 2024-11-30 NI683454 uk-core:RetainedEarningsAccumulatedLosses 2023-11-30 NI683454 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-11-30 NI683454 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-11-30 NI683454 uk-bus:FRS102 2023-12-01 2024-11-30 NI683454 uk-core:Goodwill 2023-12-01 2024-11-30 NI683454 uk-core:LandBuildings 2023-12-01 2024-11-30 NI683454 uk-core:Goodwill 2023-11-30 NI683454 uk-core:Goodwill 2024-11-30 NI683454 uk-core:CurrentFinancialInstruments 2024-11-30 NI683454 uk-core:CurrentFinancialInstruments 2023-11-30 NI683454 uk-core:WithinOneYear 2024-11-30 NI683454 uk-core:WithinOneYear 2023-11-30 NI683454 uk-core:WithinOneYear 2024-11-30 NI683454 uk-core:WithinOneYear 2023-11-30 NI683454 2023-12-01 2024-11-30 NI683454 uk-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI683454
 
 
Collinward Healthcare Ltd
 
Director's Report and Unaudited Financial Statements
 
for the financial year ended 30 November 2024
Collinward Healthcare Ltd
DIRECTOR AND OTHER INFORMATION

 
Director Mr. Lawrence Anderson
 
 
Company Registration Number NI683454
 
 
Registered Office 16 Mount Charles
Belfast
BT7 1NZ
 
 
Business Address 2 Glengormley Park
Newtownabbey
BT36 7RE
 
 
Accountants Muldoon
16 Mount Charles
Belfast
BT7 1NZ



Collinward Healthcare Ltd
DIRECTOR'S REPORT
for the financial year ended 30 November 2024

 
The director presents his report and the unaudited financial statements for the financial year ended 30 November 2024.
     
Director
The director who served during the financial year is as follows:
     
Mr. Lawrence Anderson
   
There were no changes in shareholdings between 30 November 2024 and the date of signing the financial statements.
     
In accordance with the Constitution, the director retire by rotation and, being eligible, offer themselves for re-election.
     
Political Contributions
The company did not make any disclosable political donations in the current financial year.
     
Statement of Director's Responsibilities
     
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
     
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:
- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Mr. Lawrence Anderson
Director
     
24 April 2025



Collinward Healthcare Ltd
Company Registration Number: NI683454
BALANCE SHEET
as at 30 November 2024

2024 2023
Notes £ £
 
Fixed Assets
Intangible assets 4 678,563 678,563
Tangible assets 5 273,600 279,300
───────── ─────────
Fixed Assets 952,163 957,863
───────── ─────────
 
Current Assets
Stocks 6 72,766 71,339
Debtors 7 161,511 169,315
Cash and cash equivalents 2,300 3,524
───────── ─────────
236,577 244,178
───────── ─────────
Creditors: amounts falling due within one year 8 (191,890) (163,257)
───────── ─────────
Net Current Assets 44,687 80,921
───────── ─────────
Total Assets less Current Liabilities 996,850 1,038,784
═════════ ═════════
 
Capital and Reserves
Called up share capital 10 10
Share premium account 10 996,649 996,649
Retained earnings 191 42,125
───────── ─────────
Equity attributable to owners of the company 996,850 1,038,784
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account.
           
For the financial year ended 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 24 April 2025
           
           
________________________________          
Mr. Lawrence Anderson          
Director          
           



Collinward Healthcare Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 30 November 2024

   
1. General Information
 
Collinward Healthcare Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI683454. The registered office of the company is 16 Mount Charles, Belfast, BT7 1NZ. The principal activity of the company is that of retail pharmacy. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 30 November 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Goodwill
FRS102 Section 1A requires Purchased Goodwill to be amortised over its economic useful life. The Directors consider the net book value of goodwill at ?678,563 shown in the financial statements not to be materially different to the open market value. The Directors are of the opinion that if amortisation was provided the financial statements would not show a true and fair view of the Company’s financial position. The Directors have therefore determined not to apply goodwill amortisation in the accounts. If goodwill had been amortised over a 10-year basis ?67,856 of amortisation would have been charged to the profit and loss account resulting in a current year profit after taxation of ?5,724.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Land and buildings freehold - 2% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Leasing
Rentals payable under operating leases are dealt with in the Profit and Loss Account as incurred over the period of the rental agreement.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was:
 
  2024 2023
  Number Number
 
Employees 8 6
  ═════════ ═════════
       
4. Intangible assets
     
  Goodwill Total
  £ £
Cost
At 1 December 2023 678,563 678,563
  ───────── ─────────
 
At 30 November 2024 678,563 678,563
  ───────── ─────────
Net book value
At 30 November 2024 678,563 678,563
  ═════════ ═════════
At 30 November 2023 678,563 678,563
  ═════════ ═════════
       
5. Tangible assets
  Land and Total
  buildings  
  freehold  
  £ £
Cost
At 1 December 2023 285,000 285,000
  ───────── ─────────
 
At 30 November 2024 285,000 285,000
  ───────── ─────────
Depreciation
At 1 December 2023 5,700 5,700
Charge for the financial year 5,700 5,700
  ───────── ─────────
At 30 November 2024 11,400 11,400
  ───────── ─────────
Net book value
At 30 November 2024 273,600 273,600
  ═════════ ═════════
At 30 November 2023 279,300 279,300
  ═════════ ═════════
       
6. Stocks 2024 2023
  £ £
 
Finished goods and goods for resale 72,766 71,339
  ═════════ ═════════
 
The replacement cost of stock did not differ significantly from the figures shown.
       
7. Debtors 2024 2023
  £ £
 
Trade debtors 72,317 65,188
Director's current account (Note 12) 78,473 93,899
Taxation  (Note 9) 7,158 5,893
Prepayments and accrued income 3,563 4,335
  ───────── ─────────
  161,511 169,315
  ═════════ ═════════
       
8. Creditors 2024 2023
Amounts falling due within one year £ £
 
Bank overdrafts 11,829 19,895
Trade creditors 119,252 93,007
Taxation  (Note 9) 56,582 39,490
Other creditors - 6,452
Accruals:
Pension accrual 484 496
Other accruals 3,743 3,917
  ───────── ─────────
  191,890 163,257
  ═════════ ═════════
       
9. Taxation 2024 2023
  £ £
 
Debtors:
VAT 7,158 5,893
  ═════════ ═════════
Creditors:
Corporation tax 31,197 28,719
PAYE / NI 25,385 10,771
  ───────── ─────────
  56,582 39,490
  ═════════ ═════════
   
10. Reserves
 
Share Premium Reserve
 
Share Premium amount on incorporation.
 
       
11. Capital commitments
 
The company had no material capital commitments at the financial year-ended 30 November 2024.
   
12. Director's advances, credits and guarantees
 
During the financial year, the company made a loan to a director amounting to £78,473. The loan is repayable on 31 August 2025.
   
13. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.